Introduction {#s0005}
============

The genus *Salvia* is the largest genus in the family Lamiaceae (mint family) comprising about 1000 species of shrubs, annuals and perennials [@b0005], [@b0010]. *Salvia* species have been used for centuries for the treatment of various ailments. The representative plant of this genus *Salvia officinalis* L. is commonly used in the form of an aqueous infusion to treat cough, bronchitis, asthma and digestive disturbances [@b0015]. The essential oils and fractionated extracts of this plant have been shown to possess cytotoxic and antiviral properties [@b0020], [@b0025]. In Chinese medicine, roots of *Salvia miltiorrhiza* (Danshen) have been long used for longevity and to treat cardiovascular problems such as hypertension, angina, myocardial infarction and ischemic stroke [@b0030], [@b0035]. *Salvia moorcroftiana* roots are used to treat cough and cold, while its seeds are used to treat diarrhea [@b0040], [@b0045].

The genus *Salvia* is rich in low molecular weight compounds such as sesquiterpenoids of germacrane, carotane, caryophyllane and guaiane classes; diterpenoids of abietane, clerodane, pimarane, labdane and other classes; sesterterpenoids of C-23 and C-25 classes; triterpenoids of ursane, oleanane, lupane and dammarane classes; phenolic acids and flavonoids [@b0050]. Many compounds isolated from various *Salvia* species exhibit interesting biological activities such as antimicrobial, antiviral, anticancer and antioxidant activities. Tanshinones, the most well-known compounds first isolated from *S. miltiorrhiza* and other species, are known for their antioxidant [@b0055], anti-inflammatory [@b0060], anticancer [@b0065], antibacterial and antiplatelet aggregation activities [@b0070]. Salvianolic acid A and B, isolated from various *Salvia* species, show antioxidant and cardioprotective activities [@b0075]. Specific compounds reported from plants included in this study have also shown promising biological activities. For example, 5-hydroxy-7,4′-dimethoxyflavone isolated from *S. moorcroftiana* has shown inhibitory activities against α-glucosidase [@b0080]. Nubiol isolated from *S. nubicola* has been proven active against *Pseudomonas aeruginosa* [@b0085]. Ethyl acetate fractions of *S. Plebeia* and the isolated compound 6-methoxyluteolin-7-glucoside have shown antioxidant properties [@b0090], [@b0095].

Natural products have always played a key role in the discovery of novel drugs. It has been estimated that about half of new drugs approved by the FDA during 1981--2014 were either natural products, their mimics or their derivatives [@b0100]. However, the content of natural products in a plant, in qualitative and quantitative terms, varies due to several factors such as the weather. This makes the traditional isolation and characterization of natural products even more tedious and difficult than it already is. To overcome this problem, it is essential to obtain reliable metabolic profiles that represent the characteristics and pharmacologically active natural products of a plant. Metabolic profile development requires prior identification of natural products for which HPLC-MS/MS is a fast and reliable approach. It is often done without the use of chemically pure standards since the availability of a compound in question through synthesis, isolation or commercial sources is not always possible. Another problem in addition to the unavailability of pure standards is that every plant specie can have its own unique chemistry. This poses a big challenge to the development of a versatile chromatographic method that can be used to analyze a diverse range of plant extracts. Even if a method is versatile enough to effectively separate many components of a mixture, the level of certainty of natural product identification through mass spectrometry varies depending upon what information is available. Unambiguous identification is only possible when a purified standard is available. However, in the case of a large metabolomics study, it is neither economical nor practical to have a large number of purified standards available. In cases where purified standards are unavailable, it is still possible to identify natural products in a sample based on accurate mass and MS/MS fragmentation data [@b0105]. The available information is what constitutes the so-called "identification levels" in metabolomics [@b0110]. Unambiguous identification using a standard is termed Level 1, while Level 2 is used for identification using MS/MS fragmentation data. Since Level 1 is only achievable in a small number of cases, Level 2 is the most commonly used level of natural product identification using mass spectrometry.

We present herein a direct and high-throughput approach for the profiling of flavonoids and terpenoids in five important *Salvia* species along with quantitation of twenty-one bioactive principles in the same number of plants. The five *Salvia* species included in this study have been long used in the indigenous medicinal system of Indo-Pak region but, a comprehensive approach for the dereplication of natural products in these species has never been reported. The high-throughput screening method developed in this study is an approach that presents a clear picture of the natural product content of the studied *Salvia* species. The knowledge of what natural products are present in a plant can serve as a means of discovery of potential drug leads. The current study can prove useful for bioactivity-guided drug discovery from *Salvia* species and study various biochemical pathways in plant metabolomics.

Experimental {#s0010}
============

Chemicals and reagents {#s0015}
----------------------

Compounds **2--3**, **6--8**, **11**, **15** and **17--20** were purchased from Sigma-Aldrich (Riedstr. 2 D-89555, Steinheim 49 7329 970, Germany) while compounds **1**, **4--5**, **9--10**, **12--14**, **16** and **21** ([Table 1](#t0005){ref-type="table"}) were previously isolated by our research group from various sources. All analytes including their class, formula, molecular weight and the instrument polarity used for analysis are listed in Table S1. Formic acid was used as an additive for the mobile phase and purchased from Daejung (Daejung Chemicals & Metals Co. Ltd., Korea). Methanol (MeOH) and acetonitrile (ACN) for mobile phase ware purchased from Merck (Merck KGaA, Darmstadt, Germany) and Daejung (Daejung Chemicals & Metals Co. Ltd., Korea), respectively. Type I water (ISO 3696) for the mobile phase was obtained from Barnstead™ GenPure™ ultrapure water system (Thermo Fisher Scientific Inc., USA).Table 1Optimized MS/MS parameters for compounds **1--21**.AnalyteCompound analyzedRetention time*m*/*z*Ion typeFragmentation amplitudeMRM transitions**1**Apigenin-7-*O*-glucoside3.15431.3\[M−H\]^−^90431.3 → 269.1, 311.2**2**Salvianolic acid B4.19717.6\[M−H\]^−^75717.6 → 519.2, 321.1**3**Salvianolic acid A4.55517.1\[M+Na\]^+^75517.1 → 337.0, 319.0, 221.0**4**(2*S*,3*R*)-Morelloflavone-7-*O*-rhamnopyranoside4.74703.3\[M+H\]^+^55703.3 → 541.1, 415.1**5**(2*S*,3*R*)-Volkensiflavone-7-*O*-rhamnopyranoside4.81731.6\[M+HCOOH-H\]^−^65731.6 → 514.4, 463.1, 605.3, 443.2, 569.3**6**Luteolin4.83285.1\[M−H\]^−^100285.1 → 217.0, 175.0, 151.0**7**Quercetin4.84301.1\[M−H\]^−^100301.1 → 179.0, 151.0**8**Apigenin5.41269.1\[M−H\]^−^105269.1 → 149.0**9**(2*S*,3*R*)-Morelloflavone5.43557.1\[M+H\]^+^80557.1 → 451.1, 405.1, 431.0**10**Naringenin5.49271.1\[M−H\]^−^90271.1 → 177.0, 151.0**11**Diosmetin5.55299.1\[M−H\]^−^110299.1 → 284.1**12**(2*S*,3*R*)-Volkensiflavone5.77541.1\[M+H\]^+^85541.1 → 415.0, 389.0**13**Chrysin6.31253.1\[M−H\]^−^110253.1 → 209.0, 181.0**14**3,5,7-Trimethoxyflavone6.5313.0\[M+H\]^+^125313.0 → 298.0, 269.0**15**Salvinorin A6.83455.1\[M+Na\]^+^85455.1 → 238.9, 395.0**16**3-Methylflavone7.02237.0\[M+H\]^+^130237.0 → 178.0, 133.0**17**Carnosic acid7.19331.2\[M−H\]^−^75331.2 → 303.1, 285.1**18**Carnosol7.2329.3\[M−H\]^−^60329.3 → 285.3**19**Cryptotanshinone7.57297.1\[M+H\]^+^100297.1 → 279.0, 251.0**20**Tanshinone IIA7.97295.0\[M+H\]^+^87295.0 → 277.0, 249.0**21**Rutin8.06611.3\[M+H\]^+^70611.3 → 471.8, 317.1

Instrumentation and experimental conditions {#s0020}
-------------------------------------------

HPLC-MS/MS analysis for natural product identification was performed on Bruker maXis II™ HR-QTOF mass spectrometer (Bremen, Germany) coupled to Dionex UltiMate™ 3000 series HPLC system (Thermo Fisher Scientific, Waltham, MA, USA) fitted with a binary RS pump, column thermostat and auto-sampler. Sample chromatography was performed on Macherey-Nagel Nucleodur® C18 Gravity column (3.0 × 100 mm, 1.8 µm) kept at 40 °C. 4-µL sample was injected while the mobile phase consisted of A (0.1% formic acid in H~2~O) and B (0.1% formic acid in MeOH). Mobile phase flow rate was set at 0.7 mL/min using a linear gradient of A and B starting at 10% B, increased to 90% B in 5.5 min, maintained at 90% for 1.5 min, and returned to 10% B in 1 min. Total run time was 10 min including a 1-min holding time at the start and 1-min equilibration time at the end of the gradient.

Mass spectra were recorded using electrospray ionization employing the Bruker CaptiveSpray™ ion source. MS and MS/MS spectra were recorded separately both in positive and negative mode. Ion source parameters used are mentioned as follows (parameters for negative mode next to positive mode parameters): capillary voltage at 4500 V (−3500 V), end plate offset at 500 V, nebulizer gas 45.0 psi, drying gas at 12.0 L/min and drying gas temperature at 270 °C. All spectra were recorded in the mass range from *m*/*z* 100 to 2000 while the scan speed was set at 5 Hz for MS while 12 Hz for MS/MS spectra. The active exclusion feature of the instrument was used which enables the instrument to remove a precursor ion from consideration from further consideration after a set number of MS/MS spectra have been recorded for that particular precursor ion. The active exclusion number was set at 3, and the precursor reconsideration time was set at 30 s.

HPLC-MS/MS analysis for quantitation was performed on Bruker amaZon™ speed ion trap mass spectrometer (Bremen, Germany) coupled to Dionex UltiMate™ 3000 series HPLC system (Thermo Fisher Scientific, Waltham, MA, USA) fitted with a binary pump, column thermostat and auto-sampler. Chromatographic separation of analytes was achieved on the reverse-phase C-Phenyl column (Agilent ZORBAX Eclipse XDB-Phenyl 4.6 × 75 mm, 3.5 µm) kept at 40 °C. A 4-µL sample was injected while the mobile phase consisted of A (0.1% formic acid in H~2~O) and C (0.1% formic acid in ACN). Mobile phase flow rate was set at 0.6 mL/min using a linear gradient of A and C starting at 25% C, increased to 95% C in 6 min, maintained at 95% for 1 min, and returned to 25% C in 1 min. Total run time was 10 min including a 1-min holding time at the start and 1-min equilibration time at the end of the gradient.

Mass spectra for quantitation were recorded under positive and negative modes as appropriate for the individual analyte (Table S1). Ion source parameters were as follows: capillary voltage at 4500 V (−3500 V for negative mode), end plate offset at 500 V, nebulizer gas 35.0 psi, drying gas at 8.0 L/min and drying gas temperature at 250 °C. Mass spectra scan range was set at *m*/*z* 50 to 850 while the number of spectral averages was set at 5. Ion charge control (ICC) was used for transferring a certain number of ions to the ion trap. ICC was set at 200,000 while the accumulation time was 100 ms. Fragmentation was performed under collision-induced dissociation (CID) with a time interval of 1.0 s between MS and MS/MS while the fragmentation time was set at 20 ms. Fragmentation amplitude was optimized for each analyte to obtain the maximum abundance of fragment ions. [Table 1](#t0005){ref-type="table"} summarizes optimized MS/MS parameters for all analytes.

Method performance {#s0025}
------------------

All MS and MS/MS data was saved using both profile and line spectra to minimize the possibility of instrumental noise being mistaken as a precursor ion. For qualification of precursor ion for MS/MS analysis, isotopic pattern matching (hereto referred to as the mSigma value). Mass spectra for all samples were recorded under both ionization modes (positive and negative) to counter check the authenticity of a molecular ion peak while active exclusion was used to minimize the chance of common contaminant peaks being put under MS/MS fragmentation. Each sample was injected in triplicate. A pooled QC sample was prepared by combining all plant extracts to check the accuracy of data by comparing the identified compounds in a sample against the QC sample.

The performance of the developed quantitation method was assessed through the determination of accuracy and precision. Accuracy (% bias) and precision (% RSD) were assessed by analyzing three different QC samples with six replicates for intra-day and twelve replicates (Two days, six replicates/day) for inter-day analysis. The accuracy of analysis was calculated using the expected concentration (C~E~) and the mean value of measured concentration (C~M~) by using the following relation: Accuracy (bias, %) = \[(C~E~ − C~M~)/C~E~\] × 100. Similarly, relative standard deviation, % RSD was used as an indicator of analytical precision and calculated from the standard deviation and mean value of measured concentrations by the following equation: Precision (RSD, %) = (Standard Deviation (SD)/C~M~) × 100. LOD and LOQ values for the analyzed compounds were calculated using the standard deviation of the response (σ) and the slopes (S) i.e. LOD = 3.3σ/S and LOQ = 10σ/S.

Method performance was further evaluated through the analysis of fortified samples prepared by spiking additional amounts of compounds **1**, **2--3**, **6--8**, **11** and **17--19** at three levels of 100, 200 and 400 ng/mL, respectively in the original sample solutions used for analysis.

Sample preparation {#s0030}
------------------

Shade-dried plant material (whole plant) was crushed using a dry mill. 1 g of each plant was accurately weighed and extracted with 10 mL methanol through sonication for 20 min. Each sample was centrifuged for 15 min at 6000 rpm to settle large particles, and the supernatant was filtered through a 0.22 µm PTFE syringe-driven filter. 50 µL of the filtered extract was diluted to 1000 µL with methanol for LC-MS and LC-MS/MS analysis.

For quantitation 1 mg of each standard compound was weighed and dissolved into 1 mL methanol to prepare standard stock solutions. These solutions were diluted with 50:50 water: ACN in a serial manner to prepare eight calibrant solutions ranging from 50 to 1500 ng/mL. Analysis of plant samples was performed using diluted plant extract. 50 µL of filtered plant extract was diluted to 1500 µL with 50:50 water: ACN for LC-MS/MS analysis.

Spiked samples for method validation were prepared in a similar manner as the plant samples. 50 µL of filtered plant extract plus an amount of standard solution equivalent to spike concentrations of 50, 100 and 150 ng/mL were diluted to a final volume of 1500 µL with 50:50 water: ACN for three samples, and labelled as S1, S2 and S3, respectively.

Spiked samples for method validation were prepared in a similar manner as the plant samples. 50 µL of filtered plant extract plus an amount of standard solution equivalent to spike concentrations of 100, 200 and 400 ng/mL was diluted to a final volume of 1500 µL with 50:50 water: ACN for three samples and labelled as S1, S2 and S3, respectively.

Results and discussion {#s0035}
======================

LC-MS/MS optimization {#s0040}
---------------------

The profiling of *Salvia* species was performed through an untargeted metabolomics workflow. Chromatographic optimizations included the variation of the mobile phase gradient to obtain an optimum separation of visible peaks. It was found that an optimum separation was achieved on a linear gradient starting at 10% B and reaching 90% in 5.5 min. A pooled sample was prepared by mixing crude extracts of each plant. The aim of preparing a pooled sample was to optimize the chromatography on a sample as complex as possible so that the optimized method could be used effectively for samples with varied chemistry and natural product composition. [Fig. 1](#f0005){ref-type="fig"} shows a TIC chromatogram on the pooled sample of *Salvia* species. The numbers on the peaks correspond to compounds numbers as mentioned in [Table 3](#t0015){ref-type="table"}. Good separation was achieved in a total run time of 10 min with most of the peaks separated by baseline. The developed method was able to effectively analyze plant samples belonging to different species and no carryover peaks were detected in consecutive runs. In addition to the optimization of separation efficiency, we also optimized the method for MS signal intensities so that most sensitive quantitation results could be obtained. To obtain the maximum number of data points for maximum sensitivity, the scan frequency of the instrument was kept at maximum (12 Hz). To decrease the level of noise in the data, the active exclusion was used to avoid contaminant peaks (from the solvent) being put under MS/MS fragmentation. Precursor reconsideration time was set at 0.5 min after careful examination of the peak widths. This reconsideration time ensured that no precursor ions were excluded from the MS/MS analysis. To ensure that the recorded data was of high accuracy, every LC-MS/MS run was accompanied by a calibration segment at the start of the analysis. The calibration segment lasted for 0.3 min, during which the instrument was injected with sodium formate (10 mM in 1:1 water:2-propanol) at a flow rate of 3 μL/min. Calibration was performed through a comparison of obtained *m*/*z* values of sodium formate clusters with the known *m*/*z* values.Fig. 1TIC chromatogram of the pooled sample from *Salvia* species.Table 2Selection of optimum stationary phase.S. No.ManufacturerColumnDimensionsFlow rate (mL/min)Temperature (°C)Gradient usedWell-resolved peaksPeak capacity1Macherey-NagelNucleodur C18 Gravity3 × 100 mm, 1.8 µm particle size0.74020% C, 0--1 min; 20--95% C, 1--7 min; 95% C, 7--8 min; 95--20% C, 8--9 min; 20% C, 9--10 min.452.6120.74030% C, 0--1 min; 30--95% C, 1--7 min; 95% C, 7--8 min; 95--30% C, 8--9 min; 30% C, 9--10 min.972.283AgilentZorbax Eclipse XDB-C184.6 × 100 mm, 1.8 µm particle size0.64030% C, 0--1 min; 30--60% C, 1--3 min; 60% C, 4 min; 60--95% C, 4--6.5 min; 95% C, 6.5--8 min; 95--30% C, 8--9 min; 30% C, 9--10 min.975.614AgilentZorbax Eclipse XDB-Phenyl4.6 × 75 mm, 3.5 µm particle size0.64025% C, 0--1 min; 25--95% C, 1--7 min; 95% C, 7--8 min; 95--25% C, 8--9 min; 25% C, 9--10 min.1781.225AgilentZorbax Eclipse XDB-CN4.6 × 75 mm, 3.5 µm particle size0.64025% C, 0--1 min; 25--95% C, 1--7 min; 95% C, 7--8 min; 95--25% C, 8--9 min; 25% C, 9--10 min.1558.02Table 3Table of compounds detected in *Salvia* species (positive and negative ionization modes).S. No.Compound NameFormulaRT (min)Ion Type*m*/*z* Measured*m*/*z* CalculatedError (ppm)mSigmaMS/MSMSI level16-Hydroxyluteolin-7-*O*-glucosideC~21~H~20~O~12~3.25\[M−H\]^−^463.0878463.0882−0.8632.9301.034922Nubenoic acidC~15~H~20~O~5~3.25\[M+H\]^+^281.1387281.13841.0749.7245.1189, 203.1061, 201.0917, 187.07622\[M−H\]^−^279.1238279.12380.0029.8261.1142, 235.1338, 217.1277, 202.10003*trans*-*p*-Coumaric acidC~9~H~8~O~3~3.34\[M−H\]^−^163.0403163.04011.23NCNP24Luteolin-7-*O*-glucosideC~21~H~20~O~11~3.37\[M−H\]^−^447.0936447.09330.6731.4285.0403256-Methoxyluteolin-7-*O*-glucosideC~22~H~22~O~12~3.41\[M+H\]^+^479.1184479.11840.0016.2317.0655, 302.04192\[M−H\]^−^477.1033477.1038−1.0518.3462.0798, 315.0508, 299.019366-Hydroxyluteolin-7-*O*-glucosideC~21~H~20~O~12~3.42\[M−H\]^−^463.0878463.0882−0.8644.7301.0358, 300.027427Plebeiolide GC~15~H~20~O~4~3.45\[M+H\]^+^265.1431265.1434−1.13NC247.1316, 229.1210, 219.1746, 183.116128Luteolin-7-*O*-glucuronideC~21~H~18~O~12~3.45\[M−H\]^−^461.0721461.0725−0.8729.7NF29LoliolideC~11~H~16~O~3~3.46\[M+H\]^+^197.1171197.1172−0.5125.2179.1070, 161.0969, 151.1130210Rosmarinic acidC~18~H~16~O~8~3.49\[M−H\]^−^359.0771359.0772−0.2815.4197.0454, 179.0351, 161.0244, 151.04032118-Methoxygenistein-7-*O*-*α*-L-rhamnoside-4′-*O*-*β*-D-glucosideC~28~H~32~O~15~3.48\[M+H\]^+^609.1820609.18140.9829.1301.0707, 463.12352\[M−H\]^−^607.1671607.16680.4939299.0560, 284.030912Apigenin-7-*O*-glucoside[†](#tblfn1){ref-type="table-fn"}C~21~H~20~O~10~3.52\[M−H\]^−^431.0981431.0984−0.7045.7269.0444113Plebeiolide AC~17~H~24~O~6~3.56\[M+Na\]^+^347.1475347.14652.88287.12922\[M+H\]^+^325.1645325.1646−0.3146.7323.1846, 247.1338, 229.1227\[M−H\]^−^323.1491323.1500−2.7925281.1407, 279.1233, 237.1492141*α*-Hydroxy-2-oxoeudesman-3,7(11)-dien-8*β*,12-olideC~15~H~18~O~4~3.57\[M+H\]^+^263.1278263.12780.0046.4245.1172, 243.1013, 217.1222, 227.1054, 203.10752\[M−H\]^−^261.1137261.11321.9122.7246.0899, 217.1234, 202.099615SalviacoccinC~20~H~20~O~6~3.61\[M+H\]^+^357.1335357.13330.5617.6339.1235, 293.1173, 245.0804, 181.10122\[M−H\]^−^355.1196355.11872.5316.5311.1276, 288.1754, 287.064516Salvidivin CC~23~H~28~O~10~3.68\[M−H\]^−^463.1612463.16100.4348.3NF217NubdienolideC~15~H~18~O~5~3.73\[M−H\]^−^277.1078277.1081−1.0814.4NF218NubenolideC~15~H~16~O~4~4.09\[M+H\]^+^261.1120261.1121−0.3847.7243.1011, 233.1172, 217.1223, 215.1064, 189.09092\[M−H\]^−^259.0982259.09762.3215.1NF19NubatinC~17~H~16~O~7~3.80\[M−H\]^−^331.0824331.08230.3031.4316.0579, 301.0358, 195.0298, 135.0461220SalvitinC~16~H~12~O~6~3.83\[M−H\]^−^299.0561299.05610.0023.6284.0327, 256.0352221Luteolin[†](#tblfn1){ref-type="table-fn"}C~15~H~10~O~6~3.87\[M+H\]^+^287.0551287.05500.3544.6NF1\[M−H\]^−^285.0405285.04050.0015.5283.0238, 255.0291, 151.002422Castanin EC~15~H~20~O~6~3.96\[M−H\]^−^295.1194295.11872.3727.6233.1192223NubenoneC~15~H~16~O~4~4.12\[M+H\]^+^261.1124261.11211.1547.3243.1030, 215.1063, 201.0915, 189.0917224Apigenin[†](#tblfn1){ref-type="table-fn"}C~15~H~10~O~5~4.13\[M+H\]^+^271.0603271.06010.7448.3NF1\[M−H\]^−^269.0452269.0455−1.1224.0225.055925Diosmetin[†](#tblfn1){ref-type="table-fn"}C~16~H~12~O~6~4.17\[M+H\]^+^301.0707301.07070.0027.7286.0472, 258.0531, 168.00411\[M−H\]^−^299.0564299.05611.0017.7284.033126NubiolC~15~H~18~O~3~4.35\[M+H\]^+^247.1328247.1329−0.4010.3229.1221, 201.1275, 183.1171, 214.0987227TakakinC~16~H~12~O~6~4.74\[M−H\]^−^299.0568299.05612.3436.8284.0325228Przewalskinone BC~16~H~12~O~5~5.24\[M−H\]^−^283.0614283.06120.7117.5268.0380229SalviviridinolC~21~H~32~O~4~6.29\[M−H\]^−^347.2224347.2228−1.15NC345.2102, 315.1965230SalvinoloneC~20~H~26~O~3~6.42\[M−H\]^−^313.1804313.1809−1.6030.1311.1679, 298.1576231Santolinoic acidC~30~H~48~O~5~6.47\[M−H\]^−^487.3424487.3429−1.0333.0469.3287, 451.2690, 443.3494,232Isopimara-6,8(14),15-trieneC~20~H~30~6.49\[M+H\]^+^271.2423271.24201.1149.4215.1794, 201.1644, 229.1958, 159.1181, 189.1637, 177.1641233Carnosol~†~C~20~H~26~O~4~6.50\[M+H\]^+^331.1899331.1904−1.51NC287.1994, 177.16421\[M−H\]^−^329.1758329.17580.0025.3NF343*β*-Hydroxydehydroabietic acidC~20~H~28~O~3~6.54\[M−H\]^−^315.1971315.19661.5940.6313.1781, 271.2070, 289.33192352-(2-Acetoxypentadecyl)-6-hydroxy-4-methoxybenzoic acidC~25~H~40~O~6~6.55\[M−H\]-435.2753435.27520.2330.5375.2545, 349.2738236NemorosinC~20~H~28~O~4~6.71\[M−H\]^−^331.1921331.19151.8127.3313.1818, 287.2019, 285.1856237SalvimirzacolideC~25~H~38~O~5~6.72\[M−H\]^−^417.2646417.26460.0048.5373.2766, 221.1547238Divinatorin AC~20~H~28~O~4~6.92\[M+H\]^+^333.2051333.2060−2.70NC331.1829, 315.1955, 287.2006, 273.18512\[M−H\]^−^331.1914331.1915−0.3050.0329.1758, 313.1826, 287.2025, 285.187439Cryptotanshinone~†~C~19~H~20~O~3~6.96\[M+H\]^+^297.1499297.14806.3950.0238.0761140CryptanolC~20~H~28~O~3~7.03\[M−H\]^−^315.1965315.1966−0.3243.2299.1652, 285.1879, 243.103424116-Hydroxy-6,7-didehydroferruginolC~20~H~28~O~2~7.13\[M−H\]^−^299.2017299.20170.0047.4227.109424219-Acetoxy-15,16-epoxy-6-hydroxy-ent-cleroda-3,13(16),14-trien-18-alC~22~H~32~O~5~7.16\[M−H\]^−^375.2184375.21771.8745.6343.1920, 328.1680, 313.1448243Carnosic acid[†](#tblfn1){ref-type="table-fn"}C~20~H~28~O~4~6.82\[M−H\]^−^331.1914331.1915−0.3049.9313.1822, 329.1778, 287.2018, 285.1868144Divinatorin CC~22~H~30~O~5~7.61\[M−H\]^−^373.2021373.20200.2748.0373.2021, 331.1915, 313.1809, 287.2018, 285.1878245Isopimara-8(14),15-dieneC~20~H~32~7.71\[M+H\]^+^273.2575273.2577−0.7348.1217.1950, 203.1794, 191.1796246RoyleanoneC~20~H~28~O~3~7.93\[M−H\]^−^315.1966315.19660.0041.4299.1671, 243.10362477*α*-Hydroxy-14,15-dinorlabd-8(17)-en-13-oneC~18~H~30~O~2~8.80\[M+H\]^+^279.2297279.2319−7.88NC261.2232, 149.09692\[M−H\]^−^277.2170277.2173−1.0812.3277.2170, 259.2058, 233.1543, 205.1590[^1][^2][^3][^4]

An important parameter related to the sensitivity of a quantitation method is the instrument duty cycle which is greatly reduced if many analytes elute at retention times close to each other. This results in the instrument being busy performing MS/MS fragmentation on too many ions in a tiny time window. To increase the instrument duty cycle, it was necessary to optimize the chromatographic separation in such a way that all analytes elute at retention times as much different from one another as possible. We started the optimization of chromatography by careful examination of the physicochemical characteristics of compounds **1--21**. [Fig. 2](#f0010){ref-type="fig"} shows a chemical space of compounds **1--21** using three important parameters: exact mass, LogP and number of hydrogen bonds. The use of these three parameters gave an impression of analyte polarity and affinity for stationary and mobile phases. It was found that the LogP values for most of the analytes ranged from 1.33 to 3.63 and only five compounds had LogP values out of this range. We used four different columns under various mobile phase compositions and the results were compared in terms of peak capacities and the number of well-resolved peaks. [Table 2](#t0010){ref-type="table"} lists the columns used along with the calculated peak capacities and the number of well-resolved peaks. A visual comparison among column peak capacities, the total number of eluted peaks and the number of well-resolved (baseline-separated) peaks can be seen in [Fig. 3](#f0015){ref-type="fig"}. Numbers on the Y-axis correspond to the serial number of experiments as listed in [Table 2](#t0010){ref-type="table"}. Chromatographic parameters such as the mobile phase flow rate, gradient composition and column temperature were all varied and the effect of each was seen on the separation of analytes. It was observed that greater ACN percentages at the start of a chromatographic run resulted in better peak shapes but a narrow range of retention times. On the contrary, smaller percentages of ACN resulted in distorted peak shapes. Good peak shapes and optimum separation was achieved at 25% ACN at the start of the run. The optimum column temperature was found to be 40 °C and the best flow rates were 0.6--0.7 mL/min. It should be noted that [Table 2](#t0010){ref-type="table"} only lists the best chromatographic conditions used for each column used in method development and optimization. The obtained chromatograms are shown in [Fig. 4](#f0020){ref-type="fig"}.Fig. 2Chemical space of compounds **1--21** used for quantitation.Fig. 3Comparison of separation efficiencies of different columns used in quantitation method development.Fig. 4HPLC-UV Chromatograms showing separation efficiencies of columns **1--5**.

Based on the observations from these experiments, it was found that Agilent Zorbax Eclipse XDB-Phenyl was the best column for the analysis of compounds **1--21** in *Salvia* species as it gave the best peak capacities with the maximum number of well-resolved peaks with good shapes. It was concluded that the presence of phenyl rings in the stationary phase results in aromatic-aromatic interactions as all the analytes except salvinorin A (**15**) contained aromatic rings in their structures. This resulted in better retention and selectivity which can be spread throughout the entire length of chromatogram through the selection of a proper mobile phase gradient. It can be seen in [Fig. 4](#f0020){ref-type="fig"}(5) that all the analyte peaks are baseline-separated and have good retention time differences. This led to a method with optimum differences in retention times of all analytes.

HPLC-QTOF-MS/MS analysis was performed under both ionization modes (positive and negative) to ensure that all types of compounds can be ionized, detected and subsequently identified. To ensure optimum scan speed, all MS/MS spectra were recorded at a scan speed of 12 Hz so that as much as possible data could be recorded in a single HPLC-MS/MS run. Many natural products tend to be abundant and at several folds higher concentrations than other natural products. It was, therefore, necessary to ensure that MS peaks belonging to natural products present in smaller concentrations are not left without MS/MS fragmentation. To achieve this goal, we used the active exclusion feature of the instrument. It was found that an active exclusion number of 3 was optimum to acquire data containing a maximum number of MS/MS spectra. It is also very common to have multiple natural products of identical molecular weights in the same plant specie. To make sure that active exclusion does not bar the isomers from MS/MS to be performed on, the precursor reconsideration time feature was used and set at 30 s.

Eleven out of twenty-one analytes used in the quantitation study showed better MS and MS/MS signals in the negative mode ionization while ten were better observed under positive ionization mode. We did not use the instrument in the alternating polarity mode because that would have decreased the sensitivity of quantitation because of unnecessary polarity switches. Instead, we used a scheduled precursor list that contained information about ionization polarity, *m*/*z* values, and retention times of all analytes. This ensured that the instrument polarity was only switched at the time when a particular analyte was being eluted. The sensitivity of quantitation in an MS/MS method also depends upon the intensities of fragment ions. To improve the fragment ion intensities, fragmentation amplitude for each analyte was carefully tuned. For this, we monitored the intensities of fragment ions of each analyte at different fragmentation amplitudes. It was observed that fragmentation amplitudes between 60 and 130 % were optimum for all analytes. A summary of all optimized parameters for quantitation is shown in [Table 1](#t0005){ref-type="table"}.

Identification and quantification of natural products {#s0045}
-----------------------------------------------------

Analysis of data was performed on Bruker Compass DataAnalysis (ver. 4.4 SR1, 64-bit) and Bruker Compass TargetAnalysis (ver. 1.3). All obtained data were first subjected to noise removal using the spectral background subtraction algorithm built-in in DataAnalysis 4.4. Each data file was calibrated using sodium formate clusters *m*/*z* values in the high-precision calibration (HPC) mode. Compound identification strategy involved screening of obtained data based on accurate mass, mSigma, fragmentation pattern matching using a data post-processing routine [@b0115]. An *in-house* library of compounds previously known to be isolated from the genus *Salvia* was prepared after an extensive literature survey and through the use of the Dictionary of Natural Products on DVD (DNP ver. 26.2). All acquired LC-MS data, after noise removal and calibration, was screened against the built library using TargetAnalysis to get a list of candidate compounds. The candidate compounds were then filtered using their mass error and mSigma values. Every *m*/*z* value in the candidate compounds list was first checked for its mass accuracy, the tolerance for which was set at 5 ppm. Every *m*/*z* value was also checked for its mSigma value which is the measure of how good an observed isotopic pattern fits onto a simulated isotopic pattern. Smaller values of mSigma indicate a good isotopic pattern match, which in turn ensures good quality of data. The tolerance for mSigma value was set at 50.

The filtered list thus obtained was used to prepare a scheduled precursor list with retention time and *m*/*z* values of all candidate compounds. The sample was rerun in the MS/MS mode and fragmentation data was acquired. MS/MS-based identification of compounds was performed using the comparison of obtained fragment *m*/*z* values with the theoretical fragmentation patterns of candidate compounds. The theoretical fragmentation patterns were generated using the Fragmentation Explorer functionality built into DataAnalysis. The workflow for compound identification is presented in [Fig. 5](#f0025){ref-type="fig"}.Fig. 5A workflow of natural product identification using LC-ESI-MS/MS.

It was observed that most analytes, under the positive ionization mode, were observed as protonated molecules and as deprotonated molecules under negative ionization conditions. The most common fragments observed were neutral losses such as H~2~O and CO~2~. Loss of H~2~O was the predominant mode of fragmentation in positive mode followed by other modes of fragmentation. The loss of CO~2~ was prevalent in negative ionization mode for molecules containing carboxylic acid groups. The MS/MS fragmentation data was analyzed for both modes to identify compounds. For example, In positive ionization mode, nubenoic acid (Entry 2, [Table 3](#t0015){ref-type="table"}) showed the successive losses to two H~2~O molecules to form an ion of formula C~15~H~17~O~3~^+^ which appeared at an *m*/*z* of 245.1189. In the negative mode, nubenoic acid showed the loss of a water molecule to yield an anion with the formula C~15~H~17~O~4~^−^ (*m*/*z* 261.1142). The fragmentation went on to show the loss of a CO~2~ molecule and the loss of a CH~3~ radical to yield ions of formulas C~14~H~17~O~2~^−^ (*m*/*z* 217.1277) and C~13~H~14~O~2~^•−^ (*m*/*z* 202.1000), respectively. The fragmentation patterns of nubenoic acid in both modes are shown in [Figs. S1 and S2](#s0080){ref-type="sec"}. Loliolide (Entry 9, [Table 3](#t0015){ref-type="table"}) appeared in positive ionization mode as a protonated ion of formula C~11~H~17~O~3~^+^ (*m*/*z* 197.1169). It showed two neutral losses: The loss of water molecule to yield the ion of formula C~11~H~15~O~2~^+^ (*m*/*z* 179.1070) and a successive loss of CO molecule to yield the ion of formula C~10~H~15~O^+^ (*m*/*z* 151.1130). The fragmentation of loliolide is shown in [Fig. S3](#s0080){ref-type="sec"}. Carnosol (Entry 33, [Table 3](#t0015){ref-type="table"}) appeared in the positive ionization mode as a protonated ion of formula C~20~H~27~O~4~^+^ (*m*/*z* 331.1899). It showed the characteristic loss of CO~2~ molecule to yield ion of formula C~19~H~27~O~2~^+^ (*m*/*z* 287.1994). Carnosic acid (Entry 43, [Table 3](#t0015){ref-type="table"}) appeared as a deprotonated ion (C~20~H~27~O~4~^−^, *m*/*z* 331.1914). It also showed the loss of a CO~2~ molecule in the negative ionization mode to yield an ion of formula C~19~H~27~O~2~^−^ (*m*/*z* 287.2018). The fragmentation of carnosol and carnosic acid is shown in [Figs. S4 and S5](#s0080){ref-type="sec"}.

Flavonoids were identified by characteristic losses such as the loss of CO and the decomposition of molecules through retro-Diels-Alder (RDA) reaction. Such reactions were seen in both ionization modes. For example, apigenin (Entry 24, [Table 3](#t0015){ref-type="table"}) was seen as a protonated ion in the positive mode (C~15~H~11~O~5~^+^, *m*/*z* 271.0603) and as a deprotonated ion in the negative mode (C~15~H~09~O~5~^−^, *m*/*z* 269.0452). RDA in the negative ionization mode resulted in the ion of formula C~7~H~3~O~4~^−^ (*m*/*z* 151.0039). Fragmentation of apigenin in negative ionization mode is shown in [Fig. S6](#s0080){ref-type="sec"}. All compounds were identified using the same strategy. A complete list of compounds identified in *Salvia* species is shown in [Table 3](#t0015){ref-type="table"}. The MS/MS spectra of all identified compounds alongwith the assigned fragment ion structures are provided with the [supplementary data](#s0080){ref-type="sec"}.

We were able to identify forty-seven compounds based on their exact masses, mSigma values and MS/MS fragmentation pattern. Twenty compounds were identified in the positive ionization mode, forty compounds were identified in the negative ionization mode and thirteen compounds were commonly identified in both modes. Based on ion intensities observed in the positive and negative ionization modes, bar graphs were constructed that show the distribution of identified compounds in five *Salvia* species ([Fig. 6](#f0030){ref-type="fig"}). The distribution of various identified natural products in a plant specie is a unique fingerprint that can serve to identify the plant. The graphs show that the highest concentrations of compounds showing antioxidant activities are present in the three *Salvia* species: *moorcroftiana*, *nubicola* and *plebeia*. The presence of various bioactive natural products in these *Salvia* species concurs with their traditional use. The results of this dereplication study can prove useful for bioactivity-guided drug discovery. It can be achieved through bioassays and dereplication of various fractions of plant extracts and then the activity of a fraction can be attributed to the presence of specific natural products in that fraction. For example, *Salvia nubicola* has been used traditionally in China and India to treat common cough, flu, cold, asthma and inflammatory diseases [@b0120]. These activities concur with the fact that flavonoids and terpenoids isolated from *S. plebeia* show potent antiviral activities against H1N1 [@b0125].Fig. 6Distribution of identified compounds in positive mode (A) and negative mode (B).

Similar observations were also made when the developed method was applied for quantitation of analytes **1--21** in five *Salvia* species. It was found that the five species studies in this project contained varying amounts of flavonoids apigenin (**8**), diosmetin (**11**), luteolin (**6**) and quercetin (**7**) along with phenolic compounds salvianolic acid A (**3**) and B (**2**) and abietane diterpenoids carnosol (**18**) and carnosic acid (**17**). All these compounds are known to exhibit various biological activities. Carnosol (**18**) and carnosic acid (**17**) have been shown to possess anticancer, anti-inflammatory and antioxidant properties [@b0130], [@b0135], [@b0140], [@b0145]. In addition, flavonoids are well-known for their various bioactivities such as antioxidant, antidiabetic, anti-inflammatory, antibacterial, antifungal, antitumor and various other activities [@b0150], [@b0155], [@b0160], [@b0165]. The reported antibacterial and antifungal properties concur with the bioactivities of *S. nubicola* [@b0170]. *S. moorcroftiana* is shown to possess anti-inflammatory activities [@b0175]. The results of quantitation are summarized in Table S2.

Method performance and validation {#s0050}
---------------------------------

Eight calibrants for each analyte were used between the concentration range of 50 ng/mL to 1500 ng/mL. Linear calibration curves were obtained with excellent correlation coefficients (≥0.9990). LOD and LOQ values were found to be between 0.48 and 0.98 ng/mL and 1.58--3.23 ng/mL, respectively. Table S3 summarizes obtained LOD and LOQ values along with calibration equations. LOD and LOQ values indicate excellent sensitivity and selectivity of the developed method. Method accuracy and precision (intraday and interday precision) were calculated using three QC levels at 175, 625 and 1100 ng/mL, respectively. The accuracy of the method was found to be \> 95% in all cases while % RSD was found to be lower than 5% in all cases. The data for accuracy and bias of standard are listed in Table S4.

For validation of quantitation results, all plant samples were fortified with analytes **1--3**, **6--8**, **11**, and **17--19** at three concentration levels: 100, 200 and 400 ng/mL. The method used for the preparation of fortified samples remained the same as unfortified samples. The fortification (spiking) of samples was done before the final dilution stage. The fortified samples were marked as S1, S2 and S3 for fortification levels of 100, 200 and 400 ng/mL, respectively. Analyses of fortified samples showed increased concentrations of analytes **1--3**, **6--8**, **11**, and **17--19** in all samples and excellent recoveries (\>95%) were observed. The results of recovery studies are summarized in Table S5.

Conclusions {#s0055}
===========

The present study was focused on the development of a dereplication method for the identification of natural products in five *Salvia* species. A total of forty-seven compounds belonging to phenolics, flavonoids, diterpenoids and other compound families were identified. A method for quantitation was also developed for the determination of twenty-one important compounds in the five *Salvia* species. A major focus of the quantitation study was to develop a method that can be used to quantitate natural products in samples of varied chemistries. The chromatographic optimizations resulted in optimum differences in analyte retention times that led to excellent resolution and sensitivity of the developed method.

The developed dereplication and quantitation methods were effective in the analysis of five *Salvia* species with varied compositions. Due to its effectiveness, the same method or a modified version of it can be used for the dereplication of other medicinally important *Salvia* species. Such work is of great importance for people working in the field of bioactivity-guided drug discovery from plants. Furthermore, the distribution profiles can be used for plant raw material authentication and quality control of herbal formulations.
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[^1]: \*NC = Not calculated.

[^2]: ^\*\*^NP = Not performed.

[^3]: ^\*\*\*^NF = No fragmentation seen.

[^4]: Identified using standard.
